Next Article in Journal
The Role of Diet during Pregnancy in Protecting against Gestational Diabetes Mellitus in a Population with Mediterranean Dietary Habits: A Cross-Sectional Study
Previous Article in Journal
Giant Juvenile Fibroadenoma: Case Report and Review of the Literature
Previous Article in Special Issue
Comparison of Microbial Sampling Sites and Donor-Related Factors on Corneal Graft Contamination
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Clinical Outcomes of the Intraocular Lens Injector and Busin Glide for Descemet Stripping Automated Endothelial Keratoplasty in Patients with Iridocorneal Endothelial Syndrome

1
National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou 325027, China
2
The Eye Hospital and School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou 325027, China
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
J. Clin. Med. 2023, 12(5), 1856; https://doi.org/10.3390/jcm12051856
Submission received: 6 January 2023 / Revised: 10 February 2023 / Accepted: 17 February 2023 / Published: 26 February 2023
(This article belongs to the Special Issue State of the Art of Corneal Transplantation)

Abstract

Purpose: To report the outcomes of Descemet stripping automated endothelial keratoplasty (DSAEK) performed in iridocorneal endothelial (ICE) syndrome patients using the intraocular lens injector (injector), in comparison with those using the Busin glide. Methods: In this retrospective, interventional comparative study, we evaluated the outcomes of DSAEK performed using the injector (n = 12) or the Busin glide (n = 12) for patients with ICE syndrome. Their graft position and postoperative complications were recorded. Their best-corrected visual acuity (BCVA) and endothelial cell loss (ECL) were monitored over a 12-month follow-up period. Results: DSAEK was conducted successfully in the 24 cases. The BCVA improved from the preoperative 0.99 ± 0.61 to 0.36 ± 0.35 at 12 months after operation (p < 0.001), with no significant difference between the two groups (the injector group and the Busin group) (p = 0.933). ECL at 1 month after DSAEK was 21.80 ± 15.01% in the injector group, which was significantly lower than 33.69 ± 9.75% of the Busin group (p = 0.031). No surgery-related complications were observed in the 24 cases intraoperatively or postoperatively except that one case suffered from postoperative graft dislocation, without statistical difference between the two groups. Conclusions: At 1 month after surgery, the use of graft injector for delivering DSAEK-based endothelial graft may cause significantly less endothelial cell damage than the pull-through technique used in the application of Busin glide. The injector allows safe endothelial graft delivery without the need of anterior chamber irrigation, which increases the ratio of successful graft attachment.
Keywords: Descemet stripping automated endothelial keratoplasty; iridocorneal endothelial syndrome; graft inserter; endothelial cell damage; safety Descemet stripping automated endothelial keratoplasty; iridocorneal endothelial syndrome; graft inserter; endothelial cell damage; safety

Share and Cite

MDPI and ACS Style

Li, S.; Liu, Z.; Sun, B.; Zhao, Z.; Wang, H.; Zheng, Q.; Chen, W. Clinical Outcomes of the Intraocular Lens Injector and Busin Glide for Descemet Stripping Automated Endothelial Keratoplasty in Patients with Iridocorneal Endothelial Syndrome. J. Clin. Med. 2023, 12, 1856. https://doi.org/10.3390/jcm12051856

AMA Style

Li S, Liu Z, Sun B, Zhao Z, Wang H, Zheng Q, Chen W. Clinical Outcomes of the Intraocular Lens Injector and Busin Glide for Descemet Stripping Automated Endothelial Keratoplasty in Patients with Iridocorneal Endothelial Syndrome. Journal of Clinical Medicine. 2023; 12(5):1856. https://doi.org/10.3390/jcm12051856

Chicago/Turabian Style

Li, Saiqing, Zihao Liu, Binjia Sun, Zelin Zhao, Haiou Wang, Qinxiang Zheng, and Wei Chen. 2023. "Clinical Outcomes of the Intraocular Lens Injector and Busin Glide for Descemet Stripping Automated Endothelial Keratoplasty in Patients with Iridocorneal Endothelial Syndrome" Journal of Clinical Medicine 12, no. 5: 1856. https://doi.org/10.3390/jcm12051856

APA Style

Li, S., Liu, Z., Sun, B., Zhao, Z., Wang, H., Zheng, Q., & Chen, W. (2023). Clinical Outcomes of the Intraocular Lens Injector and Busin Glide for Descemet Stripping Automated Endothelial Keratoplasty in Patients with Iridocorneal Endothelial Syndrome. Journal of Clinical Medicine, 12(5), 1856. https://doi.org/10.3390/jcm12051856

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop